DOCSLIB.ORG

Author Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Author Index Author Index Abadı´a-Molina, Ana C., 5829 Champion, Matthew M., 5819 Fromm, Phillip D., 6258 Abdi, Kaveh, 5981 Chan, Megan, 5839 Fu, Mingui, 6381 Abraham, Edward, 6381 Chandy, K. George, 5877 Fujita, Natsuko, 6194 Adewale, Funmilola, 5944 Chang, Chien-Wen, 5867 Funderburg, Nicholas, 6338 Adib-Conquy, Minou, 5850 Chang, Yung-Chi, 5867 Furman, Richard R., 6071 Afergan, Fabian, 6165 Chaumeil, Julie, 6084 Alcaide, Pilar, 6287 Cheeseman, Michael T., 6371 Gais, Petra, 5833 Aleman, Marta, 5829 Chen, Chih-Yu, 5867 Gall, Jason G. D., 6109 Alessandrini, Alessandro, 6063 Chen, Huabiao, 5924 Gamrekelashvili, Jaba, 6055 Al-Harthi, Lena, 5809 Chen, Kang, 6071 Garc¸on, Fabien, 5935 Allen, Eri, 6300 Chiang, Ming-Yi, 5970 Garden, Oliver A., 5935 Allison, James P., 6156 Chiorazzi, Nicholas, 6093 Geherin, Skye A., 6027 Alt, Carsten, 6027 Chiu, April, 6071 Gelgor, Linda, 6238 Altmayr, Felicitas, 5833 Clancy, Jennifer L., 6238 Giles, Joanna, 6184 Anderson, Ben, 6238 Clayberger, Carol, 6119 Gocke, Anne R., 5877 Antoniou, Antony N., 6184 Clotet, Bonaventura, 6036 Godfrey, Sasha Blue, 5924 Aoyama, Akihiro, 6063 Cols, Montserrat, 6071 Go´mez, Carmen E., 6407 Appel, Michael Y., 6165 Cooper, David A., 6238 Gomez, Timothy S., 6135 Ashitomi, Dai, 6194 Corna, Gianfranca, 6267 Goodman, Alan G., 6407 Atkinson, Carl, 6309 Cosimi, A. Benedict, 6063 Gorman, Jacquelyn A., 6135 Azcutia, Veronica, 6287 Cossu, Giulio, 6267 Gorus, Frans K., 6319 Coulon, Pierre-Gre´goire, 6036 Gostick, Emma, 6109 Babich, Alexander, 6135 Cowley, Mark J., 6238 Grabie, Nir, 6287 Baker, Brian M., 5819 Cresswell, Peter, 6001 Grasset, Emilie K., 6018 Baldzizhar, Raman, 6319 Croce, Kevin J., 6287 Gress, Ronald E., 5859 Balzar, Silvana, 6046 Cruz-Guilloty, Fernando, 5962 Greten, Tim F., 6055 Banerjee, Sami, 6381 Cui, Huachun, 6381 Griffin, Gabriel K., 6287 Baracho, Gisele V., 6084 Cutrufello, Nicholas J., 5962 Griffin, George E., 6247 Barber, Amorette, 6389 Czyzyk, Jan, 6319 Grishkan, Inna V., 5877 Barbosa-Quintana, Oralia, 6399 Groves, Jacqueline R., 6278 Barbu, Emilia Alina, 6278 Datta, Syamal K., 5970 Grundstro¨m, Thomas, 6175 Barr, Valarie A., 6119 Davies, Anthony, 6357 Barra, Carolina M., 6071 Davis, Kasey I., 6381 Ha, Hye-Lin, 5906 Becker-Hapak, Michelle, 5839 de Freitas, Andressa, 6381 Hadad, Uzi, 6165 Benichou, Gilles, 6063 Debes, Gudrun F., 6027 Haddad, Elias, 6109 Berenstein, Elsa H., 6278 Desvignes, Ludovic, 6205 Hansen, Ted H., 5839 Berger, Scott B., 5829 Detre, Cynthia, 5829 Haque, Shabirul, 6093 Bergman, Cheryl M., 6001 Dick, Christopher J., 6135 Hauser, Jannek, 6175 Bernstein, Helene B., 6338 DiGleria, Katilin, 6184 Hawse, William F., 5819 Billadeau, Daniel D., 6135 Dillon, Stacey R., 6071 Hay, John B., 6027 Boettcher, Steffen, 5824 Ding, Yan, 5887 Hayakawa, Fumihiko, 6127 Boskovic, Svjetlan, 6063 DiVietro, Jeffrey A., 6347 He, Bing, 6071 Bosnjak, Lidija, 6216 Dosenovic, Pia, 6018 Heikenwalder, Mathias, 5824 Bosurgi, Lidia, 6267 Dreyer, Anita M., 6225 Hellman, Lance M., 5819 Bottaro, Andrea, 5944 Druey, Kirk M., 6347 Henegariu, Octavian, 6319 Bottomly, Kim, 6319 Durner, Leopold, 5990 Herold, Kevan, 6319 Boutin, Sylvie, 6418 Hevezi, Peter A., 6399 Bowness, Paul, 6184 Ecklund, Diane, 5970 Hewitt, Stephen M., 6055 Braiman, Alex, 6165 Elvington, Michelle, 6309 Hilliard, Kristie L., 6300 Brown, Steve D. M., 6371 Engel, Stanislav, 6165 Hoechst, Bastian, 6055 Brumme, Chanson J., 5924 Engels, Niklas, 6010 Holzmann, Bernhard, 5833 Brumme, Zabrina L., 5924 Erkizia, Itziar, 6036 Hong, Changwan, 5859 Brunelli, Silvia, 6267 Ernst, Joel D., 6205 Hood, Chantelle L., 6238 Bu, De-xiu, 6287 Espinosa, Diego A., 6407 Hossain, Moushumi, 5819 Burel, Julie G., 5898 Esplugues, Enric, 6319 Hsieh, Shie-Liang, 5867 Burkhardt, Amanda M., 6399 Esteban, Mariano, 6407 Hu, Haizhen, 6046 Burkhardt, Janis K., 6135 Hu, Kai, 6247 ´ Buzon, Maria J., 6036 Farrar, Michael A., 6084 Hu, Lina, 5877 Fasso`, Marcella, 6156 Hu, Qinxue, 6247 Cai, Zhijian, 5954 Favuzza, Paola, 6225 Huang, Wenjie, 6247 Calabresi, Peter A., 5877 Fedorchuk, Christine, 6319 Huang, Yuxian, 6371 Cameron, Mark J., 6109 Ferrari, Guido, 5809 Huang, Zi-Ming, 5867 Cancro, Michael P., 6018 Finn, Michael W., 6119 Cao, Xuetao, 5954 Fintushel, Sarah R., 6027 Inman, John K., 6093 Cardinaud, Sylvain, 6036 Fitting, Catherine, 5850 Ishikawa, Fumihiko, 6145 Carlson, Jonathan M., 5924 Flavell, Richard A., 6319 Izquierdo-Useros, Nuria, 6036 Carreno, Beatriz M., 5839 Flores-Guiterrez, Juan P., 6399 Carroll, Melanie L., 5898 Frahm, Marc A., 5809 Janssen, Klaus-Peter, 5833 Castiello, Luciano, 6119 Freeley, Michael, 6357 Jansson, Johan, 5944 Cavaillon, Jean-Marc, 5850 Fresno, Manuel, 5829 Jaron-Mendelson, Michal, 6165 Ceden˜o, Samandhy, 6036 Fricke, Jennifer, 5924 Jiang, Lingling, 5954 Cerutti, Andrea, 6071 Friggeri, Arnaud, 6381 Jin, Wei, 6247 Copyright Ó 2012 by The American Association of Immunologists, Inc. 0022-1767/12/$16.00 The Journal of Immunology 6427 Johnson, Kristen, 6084 Locastro, Shirley, 5924 Park, Jung-Hyun, 5859 Johnson, Matthew J., 6109 Long, Aideen, 6357 Parks, Lauren M., 6278 Johnson, Peter F., 5906 Lore´, Karin, 6109 Parlato, Marianna, 5850 Jones, Matthew R., 6300 Lucas, Philip J., 5859 Patel, Reema T., 6027 Joyce, Michelle V., 5819 Luciano, Angel A., 6338 Patton, Daniel T., 5935 Ju, Wei, 6156 Luckey, Megan A., 5859 Paul, Toby, 6357 Jusek, Gabriela, 5833 Luo, Sukun, 6247 Paun, Andrea, 5906 Luscinskas, Francis W., 6287 Pelletier, Nade`ge, 6018 Perez, Victor L., 5962 Kakisaka, Michinori, 6194 Ma, Chih-Yuan, 6328 Petrovas, Constantinos, 6109 Kamber, Jolanda, 6225 Ma, Jian, 5887 Pfeffer, Klaus, 5833 Kamdar, Karishma, 6399 Mack, Matthias, 6258 Pfeiffer, Steven E., 6001 Kang, Hee-Kap, 5970 Madsen, Joren C., 6063 Phipps, Simon, 5898 Kang, Jhi-Kai, 5867 Maenaka, Katsumi, 6184 Picker, Louis J., 5811 Kao, Yuan-Chung, 6328 Maganto-Garcı´a, Elena, 5829 Pierce, Brian G., 5819 Kaplan, Warren, 6238 Maganto-Garcia, Elena, 6287 Piper, Christopher, 6184 Karlsson Hedestam, Gunilla B., 6018 Manfredi, Angelo A., 6267 Pluschke, Gerd, 6225 Karlsson, Mikael C. I., 6018 Mannon, Peter, 6309 Porgador, Angel, 6165 Kashanin, Dmitry, 6357 Manns, Michael P., 6055 Prado, Julia G., 6036 Kavanagh, Daniel G., 5924 Manz, Markus G., 5824 Preston-Hurlburt, Paula, 6319 Kawai, Tatsuo, 6063 Maric, Maja, 6001 Price, David A., 6109 Kelleher, Anthony D., 6238 Marta, Cecilia B., 6001 Prinz, Petra U., 5990 Kelleher, Dermot, 6357 Martin, Eric, 5924 Pritchard, Antonia L., 5898 Keller, Hilary R., 5859 Martin, Samia, 6418 Puertas, Maria C., 6036 Kim, Grace Y., 5859 Martinez, Rosa E., 5962 Puga, Irene, 6071 Kiyono, Hiroshi, 6145 Martinez-Picado, Javier, 6036 Kling, Jessica, 6258 Mascola, John R., 6018 Kluger, Yuval, 6084 Masopust, David, 5811 Qiao, Fei, 6309 Knoll, Marko, 6010 Masouris, Ilias, 5990 Quinton, Lee J., 6300 Knowles, Daniel M., 6071 Masurier, Carole, 6418 Koenig, Alexander, 6135 Matile, Hugues, 6225 Kollnberger, Simon, 6184 Matsuda, Tadashi, 6194 Ramirez Kitchen, Christina M., 6338 Kon, Shigeyuki, 6194 Matzinger, Polly, 5981 Ramsey, Laura B., 6084 Konduru, Anuhya S., 6371 McCormick, Steven, 6093 Ramsey-Goldman, Rosalind, 5970 Kopf, Manfred, 5824 McHugh, Kirsty, 6184 Reim, Daniel, 5833 Korangy, Firouzeh, 6055 Medina-Mendez, Carlos A., 5962 Rickert, Robert C., 6084 Ko¨rner, Heinrich, 6258 Melchers, Fritz, 6010 Ridley, Anna, 6184 Koup, Richard A., 6109 Me´ndez, Catalina, 6238 Rodriguez-Plata, Maria T., 6036 Krensky, Alan M., 6119 Mendler, Anna N., 5990 Rojas-Barros, Domingo I., 5829 Kunisawa, Jun, 6145 Mentink-Kane, Margaret M., 6347 Rolf, Julia, 5935 Kurahashi, Shingo, 6127 Mesiano, Sam, 6338 Romani, Andrea M., 6338 Kurashima, Yosuke, 6145 Micsinai, Mariann, 6084 Romero, Xavier, 5829 Kuroki, Kimiko, 6184 Minami, Yosuke, 6127 Rosental, Benyamin, 6165 Kuzin, Igor I., 5944 Mizgerd, Joseph P., 6300 Rossmann-Bloeck, Tanja, 5833 Kwon, Candice Y., 6300 Moll, Markus, 6216 Roth, Norman, 6238 Kwon, Myung-Ja, 5887 Mongini, Patricia K. A., 6093 Rovere-Querini, Patrizia, 6267 Monteilhet, Virginie, 6418 Ruddle, Nancy H., 6001 Moris, Arnaud, 6036 Ryan, Veronica, 5819 Lai, Nicole Y., 5924 Moshkani, Safiehkhatoon, 5944 Rynda-Apple, Agnieszka, 6389 Le Gall, Sylvie, 5924 Moullier, Philippe, 6418 Leborgne, Christian, 6418 Muromoto, Ryuta, 6194 Lebson, Lori A., 5877 Sabatino, Marianna, 6119 Murray, Daniel D., 6238 Lee, Byung Cheol, 6371 Sahlstro¨m, Peter, 6216 Lee, Hyunjoo, 6093 Saini, Reena, 6119 Lee, Michael H., 6027 Nadazdin, Ognjenka, 6063 Saito, Yoriko, 6145 Leeansyah, Edwin, 6216 Naoe, Tomoki, 6127 Sanchez-Sampedro, Lucas, 6407 Lefebvre, Franc¸ois, 6109 Nedvetzki, Shlomo, 6165 Sandberg, Johan K., 6216 Lenart, Izabela, 6184 Newton, Gail, 6287 Sanz, In˜aki, 5944 Leonard, John P., 6071 Nguyen, Hai M., 5877 Schepp-Berglind, Jennifer, 6309 Leu, Chuen-Miin, 5867 Nieto, Jennifer, 6093 Schmid, Michael A., 5824 Li, Chang, 6247 Noessner, Elfriede, 5990 Scholz, Jean L., 6018 Li, Demin, 6184 Schoon, Renee A., 6135 Li, Jian-Dong, 6371 Oberneder, Ralph, 5990 Schwarz, Edward M., 5944 Li, Yiwen, 5962 O’Dell, Sijy, 6018 Scudamore, Cheryl, 5935 Liao, Gongxian, 5829 O’Dowd, Francis, 6357 Seddiki, Nabila, 6238 Lichtman, Andrew H., 6287 Ogbechie, Oluwatobi Awele, 5924 Seder, Robert A., 6109 Lie, Wen-Rong, 5839 Ohnishi, Kazuo, 6010 Sedgwick, Jonathon D., 6258 Liebesny, Paul, 5924 O’Keeffe, Michael S., 5829 Sekaly, Rafick-Pierre, 6109 Ligons, Davinna L., 5859 Okkenhaug, Klaus, 5935 Sekine, Yuichi, 6194 Lim, Jae Hyang, 6371 Oritani, Kenji, 6194 Selman, Moises, 6399 Lin, Gloria H. Y., 5915 Ormandy, Lars A., 6055 Sentman, Charles L., 6389 Lin, Shu-Wha, 6328 Ouellette, Andre´ J., 6399 Shankar, Sucharita P., 6347 Lindsay,
Load more

Recommended publications
  • Accepted Manuscript
    Lawrence Berkeley National Laboratory Recent Work Title CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon- driven inflammation possibly related to the presence of a pathobiont. Permalink https://escholarship.org/uc/item/7qv434pj Authors Shulzhenko, Natalia Dong, Xiaoxi Vyshenska, Dariia et al. Publication Date 2018-12-01 DOI 10.1016/j.clim.2018.09.008 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Accepted Manuscript CVID enteropathy is characterized by exceeding low mucosal iga levels and interferon-driven inflammation possibly related to the presence of a pathobiont Natalia Shulzhenko, Xiaoxi Dong, Dariia Vyshenska, Renee L. Greer, Manoj Gurung, Stephany Vasquez-Perez, Ekaterina Peremyslova, Stanislav Sosnovtsev, Martha Quezado, Michael Yao, Kim Montgomery-Recht, Warren Strober, Ivan J. Fuss, Andrey Morgun PII: S1521-6616(18)30294-8 DOI: doi:10.1016/j.clim.2018.09.008 Reference: YCLIM 8102 To appear in: Clinical Immunology Received date: 25 April 2018 Revised date: 2 August 2018 Accepted date: 16 September 2018 Please cite this article as: Natalia Shulzhenko, Xiaoxi Dong, Dariia Vyshenska, Renee L. Greer, Manoj Gurung, Stephany Vasquez-Perez, Ekaterina Peremyslova, Stanislav Sosnovtsev, Martha Quezado, Michael Yao, Kim Montgomery-Recht, Warren Strober, Ivan J. Fuss, Andrey Morgun , CVID enteropathy is characterized by exceeding low mucosal iga levels and interferon-driven inflammation possibly related to the presence of a pathobiont. Yclim (2018), doi:10.1016/j.clim.2018.09.008 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0367695A1 Wilson Et Al
    US 20160367695A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0367695A1 Wilson et al. (43) Pub. Date: Dec. 22, 2016 (54) POLYPEPTIDE CONSTRUCTS AND USES (30) Foreign Application Priority Data THEREOF Oct. 28, 2011 (AU) ................................ 2011 9045O2 (71) Applicant: Teva Pharmaceuticals Australia Pty Ltd, Macquarie Park (AU) Publication Classification (72) Inventors: David S. Wilson, Freemont, CA (US); Sarah L. Pogue, Freemont, CA (US); (51) Int. Cl. Glen E. Mikesell, Pacifica, CA (US); A6II 47/48 (2006.01) Tetsuya Taura, Palo Alto, CA (US); C07K 6/28 (2006.01) Wouter Korver, Mountain View, CA (52) U.S. Cl. (US); Anthony G. Doyle, Drummoyne CPC ..... A61K 47/48269 (2013.01); C07K 16/2896 (AU); Adam Clarke, Five Dock (AU); (2013.01); C07K 231 7/565 (2013.01); C07K Matthew Pollard, Dural (AU): 2317/55 (2013.01); C07K 2317/92 (2013.01) Stephen Tran, Strathfield South (AU); Jack Tzu Chiao Lin, Redwood City, (57) ABSTRACT CA (US) (21) Appl. No.: 15/194,926 The present invention provides a polypeptide construct (22) Filed: Jun. 28, 2016 comprising a peptide or polypeptide signaling ligand linked to an antibody or antigen binding portion thereof which Related U.S. Application Data binds to a cell Surface-associated antigen, wherein the ligand (63) Continuation of application No. 14/262,841, filed on comprises at least one amino acid Substitution or deletion Apr. 28, 2014, which is a continuation of application which reduces its potency on cells lacking expression of said No. PCT/AU2012/001323, filed on Oct. 29, 2012. antigen. Patent Application Publication Dec.
    [Show full text]
  • WO 2010/142017 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 16 December 2010 (16.12.2010) WO 2010/142017 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 48/00 (2006.01) A61P 37/04 (2006.01) kind of national protection available): AE, AG, AL, AM, A61P 31/00 (2006.01) A61K 38/21 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) Number: International Application DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/CA20 10/000844 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 8 June 2010 (08.06.2010) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/185,261 9 June 2009 (09.06.2009) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): DE- ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, FYRUS, INC .
    [Show full text]
  • Macrophage Activation: Dissociation of Cytotoxic Activity from Ia-A Antigen Expression (Fibroblast Interferon/Immune Interferon/Lymphokine) ELLIOTT J
    Proc. Nati. Acad. Sci. USA Vol. 80, pp. 2031-2035, April 1983 Immunology Macrophage activation: Dissociation of cytotoxic activity from Ia-A antigen expression (fibroblast interferon/immune interferon/lymphokine) ELLIOTT J. BLUMENTHAL, WALDEN K. ROBERTS, ADRIANA VASIL, AND DAVID W. TALMAGE Department of Microbiology and Immunology, University of Colorado Health Sciences Center, Denver, Colorado 80262 Contributed by David W. Talmage, December 20, 1982 ABSTRACT Peritoneal macrophages were obtained from MATERIALS AND METHODS DBA/2 mice that were untreated or after the injection of bacillus Cainette-Guerin (BCG), thioglycollate broth, proteose-peptone Mice. Our source of peritoneal macrophages was DBA/2 broth, or gamma-irradiated P-815 tumor cells. These macro- mice that were less than 3 months old (The Jackson Labo- phages were "activated" to become cytotoxic for a fibroblast cell ratory). line (L 929) by the addition of lymphokines (LKs), lipopolysac- Elicitation of Peritoneal Macrophages. Peritoneal exudate charide (LPS), or fibroblast interferon (IFN-.3), and the expres- cells were collected by lavage with 5 ml of sterile Eagle min- sion of I region-associated antigens (Ia-Ad) on the macrophages imal essential medium. Resident cells were removed from un- was examined both before and after activation. Thioglycollate- treated mice. Cells were also obtained (a) 3-4 days after the elicited macrophages became Ia-A' when activated by LKs, but injection of 1 ml of 3% thioglycollate in broth that had been they remained la-A- when activated by LPS or IFN-f3. Resident "aged" for at least 6 months at 40C or (b) 3 days after intra- macrophages and proteose-peptone-elicited macrophages re- peritoneal injection of 1 ml of 1% proteose-peptone broth.
    [Show full text]
  • A Role for Stat-1 in Regulating Interleukin 10 Production Following Lps Challenge
    A ROLE FOR STAT-1 IN REGULATING INTERLEUKIN 10 PRODUCTION FOLLOWING LPS CHALLENGE DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University by Jeffrey Bryan VanDeusen, B.A. * * * * * The Ohio State University 2004 Dissertation Committee: Approved by Clay Marsh, MD Christoph Plass, PhD _______________________________ Michael A. Caligiuri, MD Denis Guttridge, PhD Adviser Department of Molecular Virology, Immunology, and Molecular Genetics ABSTRACT There have been substantial advances in understanding the events that regulate gene expression at the cellular and molecular level, however, there has been limited progress integrating this information to understand how biological systems function in vivo. Complementary DNA and protein microarray technologies in combination with sophisticated bioinformatics may eventually provide important insight into how biologic systems work in vivo. We hypothesized that assessments of such events in vivo would provide new insights into the immune response that could not be predicted or discovered ex vivo. Here, we describe the use of quantitative real time RT-PCR to serially quantify expression of a variety of pro- and anti-inflammatory cytokine genes in a number of individual tissues before, during, and after challenge with lipopolysaccharide (LPS). The data provide new insight into the heterogeneity of cytokine gene expression from organ to organ following infectious insult in vivo, as well as a greater understanding of cytokine regulation. For example, the anti- inflammatory cytokine interleukin-10 (IL-10) is thought to down-regulate the effects of the pro-inflammatory cytokine interferon gamma (IFN-γ) on monocyte activation following lipopolysaccharide (LPS) stimulation.
    [Show full text]
  • Long Non-Coding RNA GRASLND Enhances Chondrogenesis Via Suppression of Interferon 4 Type II Signaling Pathway 5 Authors: Nguyen P.T
    bioRxiv preprint doi: https://doi.org/10.1101/650010; this version posted May 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Classification: Biological Sciences with a minor category of Cell Biology 2 3 Title: Long non-coding RNA GRASLND enhances chondrogenesis via suppression of interferon 4 type II signaling pathway 5 Authors: Nguyen P.T. Huynha,b,c,d, Catherine C. Glossa,b,d, Jeremiah Lorentza,b,d, Ruhang 6 Tanga,b,d, Jonathan M. Brungere, Audrey McAlindena,b,d, Bo Zhangd, Farshid GuilaKa,b,d 7 8 Short title: LncRNA GRASLND suppresses IFN to enhance chondrogenesis 9 10 Author Affiliation: 11 a. Department of Orthopaedic Surgery, Washington University in St Louis, MO, USA, 63110 12 b. Shriners Hospitals for Children – St. Louis, St. Louis, MO, USA, 63110 13 c. Department of Cell Biology, Duke University, NC, USA, 27708 14 d. Center of Regenerative Medicine, Washington University in St Louis, MO, USA, 63110 15 e. Department of Cellular and Molecular Pharmacology, University of California, San Francisco, 16 CA, USA, 94158 17 18 19 Corresponding Author: 20 Farshid Guilak 21 Campus Box 8233 22 McKinley Research Building, Room 3121 23 St Louis, MO, USA, 63110 24 Email Address: [email protected] 25 26 Keywords: mesenchymal stem cells, tissue engineering, regenerative medicine, 27 RNF144A-AS1 28 1 bioRxiv preprint doi: https://doi.org/10.1101/650010; this version posted May 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • The Role of Interferons in the Pathogenesis of Sjögren's Syndrome and Future Therapeutic Perspectives
    biomolecules Review The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives Nicoletta Del Papa 1,* , Antonina Minniti 1, Maurizio Lorini 2, Vincenzo Carbonelli 2, Wanda Maglione 1, Francesca Pignataro 1, Nicola Montano 2 , Roberto Caporali 1,3 and Claudio Vitali 4 1 Department of Rheumatology, ASST G. Pini-CTO, 20122 Milano, Italy; [email protected] (A.M.); [email protected] (W.M.); [email protected] (F.P.); [email protected] (R.C.) 2 Department of Clinical Sciences and Community Health, Ca’ Granda IRCCS Foundation, Ospedale Maggiore Policlinico, Università degli Studi di Milano, 20122 Milano, Italy; [email protected] (M.L.); [email protected] (V.C.); [email protected] (N.M.) 3 Research Center for Adult and Pediatric Rheumatic Diseases, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milano, Italy 4 Mater Domini Humanitas Hospital, Rheumatology Outpatient Clinics, 21053 Castellanza, Italy; [email protected] * Correspondence: [email protected] Abstract: There is a great deal of evidence pointing to interferons (IFNs) as being key cytokines in the pathogenesis of different systemic autoimmune diseases, including primary Sjögren’s syndrome (pSS). In this disease, a large number of studies have shown that an overexpression of type I IFN, the ‘so-called’ type I IFN signature, is present in peripheral blood mononuclear cells, and that this finding is associated with the development of systemic extra-glandular manifestations, and a Citation: Del Papa, N.; Minniti, A.; substantial production of autoantibodies and inflammatory cytokines.
    [Show full text]
  • Immunosenescence and Exercise-Mediated Modulation of the Innate Immune Response to Influenza Infection in Mice Shibani Naik Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2013 Immunosenescence and exercise-mediated modulation of the innate immune response to Influenza infection in mice Shibani Naik Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Allergy and Immunology Commons, Family, Life Course, and Society Commons, Immunology and Infectious Disease Commons, Medical Immunology Commons, and the Physical Therapy Commons Recommended Citation Naik, Shibani, "Immunosenescence and exercise-mediated modulation of the innate immune response to Influenza infection in mice" (2013). Graduate Theses and Dissertations. 13342. https://lib.dr.iastate.edu/etd/13342 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Immunosenescence and exercise-mediated modulation of the innate immune response to Influenza infection in mice by Shibani Naik A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Immunobiology Program of Study Committee: Marian Kohut, Major Professor Mark Ackermann Joan Cunnick Peter Nara Daniel Nettleton Iowa State University Ames, Iowa 2013 Copyright © Shibani Naik, 2013. All rights reserved. ii TABLE OF CONTENTS ABSTRACT iv CHAPTER 1. GENERAL INTRODUCTION Introduction to the Dissertation 01 Literature Review: Influenza viral infection 01 Immune response to influenza infection 08 Immunosenescence 25 Exercise and the Immune System 37 CHAPTER 2.
    [Show full text]
  • Ilesanmi-Oyelerephdthesis.Pdf (14.52Mb)
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. The role of dietary patterns, inflammatory status and gut microbiome in bone health maintenance of postmenopausal women – A cross-sectional study A thesis presented in fulfilment of the requirements for the degree of Doctor of Philosophy in Nutritional Science School of Health Sciences Massey University, Palmerston North Bolaji Lilian Ilesanmi-Oyelere 2020 ii To my loving husband Peter and our blessings Dafidi III & Maria II iii Abstract The incidence of postmenopausal osteoporosis (a disease in which bones become weak and brittle) is increasing in parallel with the ageing of the global population. Postmenopausal osteoporosis is characterized by increased low grade inflammation that contributes to low bone mass and degradation of bone mineral density (BMD) resulting in postmenopausal bone loss. Elevated levels of pro-inflammatory cytokines such as IL-6, TNF-α, IL-1β and RANKL are produced by activated T-cells inducing osteoclast formation and activity during senescence. The objective of the “Bugs’n’Bones” clinical study was to assess the relationship between dietary patterns, inflammatory status, gut microbiota and bone health status in New Zealand postmenopausal women. We hypothesised that lack of physical activity, increased intake of poor diets, low in fibre and nutrients, and high in fat, salt and/or sugar will increase chronic inflammation and reduce BMD. The results of this human study indicated that alongside improving physical activity status with increase in lean body mass, a nutrient pattern with high loadings of B-vitamins, calcium and phosphorus was related to an increase in BMD.
    [Show full text]
  • Liver Infiltrating T Lymphocytes Express Interferon Γ and Inducible
    Gut 2000;46:255–259 255 Liver infiltrating T lymphocytes express interferon ã and inducible nitric oxide synthase in chronic Gut: first published as 10.1136/gut.46.2.255 on 1 February 2000. Downloaded from hepatitis C virus infection S Schweyer, S Mihm, H J Radzun, H Hartmann, A Fayyazi Abstract cytokine, interferon ã (IFN-ã), has been Background—Pathogenesis of hepatitis C suggested to promote the hepatic pathology.5–7 virus (HCV) associated liver injury is Animal models of experimentally induced thought to be due to the host antiviral hepatitis support this hypothesis—for example, immune response. Using a quantitative, in a model of transgenic mice expressing IFN-ã competitive RT-PCR technique, we re- under the control of a liver specific promoter, cently showed that expression of inter- the animals developed a chronic hepatitis.8 feron ã (IFN-ã) and IFN-ã inducible type Furthermore, IFN-ã has been shown to be the of nitric oxide synthase (iNOS) is in- principal mediator of the hepatic inflammatory creased in homogenised liver tissue of process induced by syngeneic lymphocytes patients with chronic HCV infection. against hepatitis B surface antigen (HBsAg) Aims—To determine the cellular origin of expressed in the liver of transgenic mice.9 IFN-ã and iNOS expression and to exam- However, the mechanism of IFN-ã associated ine the hypothesis that T cell derived liver injury is still unclear. IFN-ã secretion induces iNOS in hepato- IFN-ã has been shown to upregulate the cytes in chronic HCV infection. inducible isoform of nitric oxide synthase Methods—By applying a non-radioactive (iNOS) in monocytes/macrophages, resulting in situ hybridisation method combined in NO production.10 As a gaseous free radical, with indirect immunofluorescence, 33 monocyte/macrophage derived NO may de- liver biopsy specimens from patients with stroy infected as well as non-infected host chronic HCV infection were studied for cells.11 Moreover, it is known that stimulated cellular expression of IFN-ã and iNOS hepatocytes can express iNOS.12 On the mRNA.
    [Show full text]
  • Non-Coding Rnas in Cartilage Development: an Updated Review
    International Journal of Molecular Sciences Review Non-Coding RNAs in Cartilage Development: An Updated Review Ehsan Razmara 1 , Amirreza Bitaraf 2, Hassan Yousefi 3, Tina H. Nguyen 3, Masoud Garshasbi 1 , William Chi-shing Cho 4,* and Sadegh Babashah 2,* 1 Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran P.O. Box 14115-111, Iran 2 Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran P.O. Box 14115-111, Iran 3 Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA 70112, USA 4 Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong * Correspondence: [email protected] (W.C.-s.C.); [email protected] (S.B.) Received: 15 August 2019; Accepted: 2 September 2019; Published: 11 September 2019 Abstract: In the development of the skeleton, the long bones are arising from the process of endochondral ossification (EO) in which cartilage is replaced by bone. This complex process is regulated by various factors including genetic, epigenetic, and environmental elements. It is recognized that DNA methylation, higher-order chromatin structure, and post-translational modifications of histones regulate the EO. With emerging understanding, non-coding RNAs (ncRNAs) have been identified as another mode of EO regulation, which is consist of microRNAs (miRNAs or miRs) and long non-coding RNAs (lncRNAs). There is expanding experimental evidence to unlock the role of ncRNAs in the differentiation of cartilage cells, as well as the pathogenesis of several skeletal disorders including osteoarthritis. Cutting-edge technologies such as epigenome-wide association studies have been employed to reveal disease-specific patterns regarding ncRNAs.
    [Show full text]
  • Lethality of SARS-Cov-2 Infection in K18 Human Angiotensin-Converting Enzyme 2 Transgenic Mice
    ARTICLE https://doi.org/10.1038/s41467-020-19891-7 OPEN Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice Fatai S. Oladunni 1,3, Jun-Gyu Park 1,3, Paula A. Pino1,3, Olga Gonzalez1,3, Anwari Akhter1,3, Anna Allué-Guardia1,3, Angélica Olmo-Fontánez1,2, Shalini Gautam1, Andreu Garcia-Vilanova 1, Chengjin Ye1, Kevin Chiem1,2, Colwyn Headley 1, Varun Dwivedi1, Laura M. Parodi1, Kendra J. Alfson1, Hilary M. Staples1, Alyssa Schami1,2, Juan I. Garcia1, Alison Whigham1, Roy Neal Platt II1, Michal Gazi1, Jesse Martinez1, Colin Chuba1, Stephanie Earley1, Oscar H. Rodriguez1, Stephanie Davis Mdaki1, Katrina N. Kavelish1, Renee Escalona1, Cory R. A. Hallam1, Corbett Christie1, Jean L. Patterson 1, Tim J. C. Anderson1, 1 1 1 1 1 1234567890():,; Ricardo Carrion Jr , Edward J. Dick Jr , Shannan Hall-Ursone , Larry S. Schlesinger , Xavier Alvarez , ✉ ✉ Deepak Kaushal 1, Luis D. Giavedoni1, Joanne Turner 1 , Luis Martinez-Sobrido 1 & ✉ Jordi B. Torrelles 1 Vaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease would benefit from validated small animal models. Here, we show that transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) by the human cytokeratin 18 promoter (K18 hACE2) represent a susceptible rodent model. K18 hACE2 transgenic mice succumbed to SARS-CoV-2 infection by day 6, with virus detected in lung airway epithelium and brain. K18 ACE2 transgenic mice produced a modest TH1/2/17 cytokine storm in the lung and spleen that peaked by day 2, and an extended chemokine storm that was detected in both lungs and brain.
    [Show full text]